undamentalytics Newsletter
Sign in

Q32 Bio Inc. revenue

Q32 Bio Inc.'s revenue was $53.7m in fiscal 2025. Since fiscal 2018 ($3.7m) it has grown at a compound 46.6% a year.

Revenue history

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Fiscal year2018Dec 20182019Dec 20192020Dec 20202021Dec 20212022Dec 20222023Dec 20232024Dec 20242025Dec 2025
Revenue4233431054
Growth on the year before—−54.8%+62.2%+>999%−90.6%−64.0%−100.0%—

Revenue as reported in the company's 10-K and 10-Q filings (for banks, net interest income plus non-interest income). Growth is left blank when the earlier figure was zero or negative.

More: Biotechnology stocks compared, Health Care sector, rankings of US companies

Figures from Q32 Bio Inc.'s SEC filings (10-K and 10-Q), retrieved November 1, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Q32 Bio Inc.